Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI):prospective pilot study

Autor: Stoop, Thomas F., van Veldhuisen, Eran, van Rijssen, L. Bengt, Klaassen, Remy, Gurney-Champion, Oliver J., de Hingh, Ignace H., Busch, Olivier R., van Laarhoven, Hanneke W. M., van Lienden, Krijn P., Stoker, Jaap, Wilmink, Johanna W., Nio, C. Yung, Nederveen, Aart J., Engelbrecht, Marc R. W., Besselink, Marc G., Bosscha, Koop, Nieuwehof-Biesheuvel, Loes van den, Marsman, Hendrik A., Seelen, Leonard W. F.
Přispěvatelé: Surgery, Internal medicine, VU University medical center, Graduate School, CCA - Cancer Treatment and Quality of Life, Amsterdam Gastroenterology Endocrinology Metabolism, Ear, Nose and Throat, Oncology, Radiology and Nuclear Medicine, CCA - Imaging and biomarkers, CCA - Cancer biology and immunology, ACS - Diabetes & metabolism, AMS - Ageing & Vitality, AMS - Sports
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: IMAGE study group 2022, ' Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI) : prospective pilot study ', Langenbeck's Archives of Surgery, vol. 407, no. 8, pp. 3487-3499 . https://doi.org/10.1007/s00423-022-02653-y
Langenbeck's Archives of Surgery, 407(8), 3487-3499. Springer Verlag
Langenbeck's Archives of Surgery. Springer Verlag
ISSN: 1435-2443
DOI: 10.1007/s00423-022-02653-y
Popis: Background Restaging of locally advanced pancreatic cancer (LAPC) after induction chemotherapy using contrast-enhanced computed tomography (CE-CT) imaging is imprecise in evaluating local tumor response. This study explored the value of 3 Tesla (3 T) contrast-enhanced (CE) and diffusion-weighted (DWI) magnetic resonance imaging (MRI) for local tumor restaging. Methods This is a prospective pilot study including 20 consecutive patients with LAPC with RECIST non-progressive disease on CE-CT after induction chemotherapy. Restaging CE-CT, CE-MRI, and DWI-MRI were retrospectively evaluated by two abdominal radiologists in consensus, scoring tumor size and vascular involvement. A halo sign was defined as replacement of solid perivascular (arterial and venous) tumor tissue by a zone of fatty-like signal intensity. Results Adequate MRI was obtained in 19 patients with LAPC after induction chemotherapy. Tumor diameter was non-significantly smaller on CE-MRI compared to CE-CT (26 mm vs. 30 mm; p = 0.073). An MRI-halo sign was seen on CE-MRI in 52.6% (n = 10/19), whereas a CT-halo sign was seen in 10.5% (n = 2/19) of patients (p = 0.016). An MRI-halo sign was not associated with resection rate (60.0% vs. 62.5%; p = 1.000). In the resection cohort, patients with an MRI-halo sign had a non-significant increased R0 resection rate as compared to patients without an MRI-halo sign (66.7% vs. 20.0%; p = 0.242). Positive and negative predictive values of the CE-MRI-halo sign for R0 resection were 66.7% and 66.7%, respectively. Conclusions 3 T CE-MRI and the MRI-halo sign might be helpful to assess the effect of induction chemotherapy in patients with LAPC, but its diagnostic accuracy has to be evaluated in larger series.
Databáze: OpenAIRE
Externí odkaz: